Search Results 121-130 of 16727 for CLL

  1. Idelalisib (oral route) - Mayo Clinic

    Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes ...

  2. Obinutuzumab (intravenous route) - Mayo Clinic

    Description. Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL).

  3. Yucai Wang, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Clinical trials for lymphoma and chronic lymphocytic leukemia. · Novel therapeutics for hematological malignancies. · Treatment and outcomes of lymphoma and ...

  4. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  5. Skin Biopsy Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia Rochester, MN. The purpose of this study is to ... CLL as well as non-CLL patients. Study to Validate Methods Assessment of ...

  6. Fludarabine (intravenous route) - Mayo Clinic

    It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL ...

  7. Hairy Cell Leukemia Clinical Trials - Mayo Clinic Research

    ... chronic lymphocytic leukemia (CLL). The Circulating Cell-free Genome Atlas Study Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. GRAIL is using deep ...

  8. Lisocabtagene maraleucel (intravenous route) - Mayo Clinic

    Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...

  9. Cancer Clinical Trials - Medical Professionals

    The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

  10. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...